Portside Wealth Group, LLC Charles River Laboratories International, Inc. Transaction History
Portside Wealth Group, LLC
- $586 Billion
- Q3 2024
A detailed history of Portside Wealth Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Portside Wealth Group, LLC holds 1,104 shares of CRL stock, worth $204,670. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,104
Previous 1,259
12.31%
Holding current value
$204,670
Previous $260 Million
16.39%
% of portfolio
0.04%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.13 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$943 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$694 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$395 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$360 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.43B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...